Breast Cancer Collaborations Group

The group encompasses all of the Breast Cancer Research positions embedded within other groups across the ICR. These roles enable connectivity between Divisions and bring together expertise across the ICR to drive forwards progress in breast cancer research.

Professor Andrew Tutt

Director of Breast Cancer Now Toby Robins Research Centre & Head of Division:

Drug Target Discovery, Breast Cancer Collaborations, Target Validation & DNA Damage Response Professor Andrew Tutt

Andrew Tutt is Head of the Division of Breast Cancer Research and Director of the Breast Cancer Now Toby Robins Research Centre at the ICR and Guy’s Hospital King’s College London. He is a Clinician Scientist with the Laboratory and Clinical Trials programme, and a Consultant Clinical Oncologist looking after women with breast cancer.

See profile

Researchers in this group

.

Phone: +44 20 3437 6184

Email: [email protected]

Location: Sutton

See profile

.

Phone: +44 20 3437 6459

Email: [email protected]

Location: Chelsea

See profile

Professor Andrew Tutt's group have written 171 publications

Most recent new publication 8/2024

See all their publications

Related news and discoveries

Left: Plates showing the impact of olaparib on BRCA cancer cells and minimal impact of on healthy cells. (Right) Lynparza, olaparib's brand name, drug packaging. Photo credit: Science Museum Group
ICR welcomes NICE recommendation of olaparib for advanced breast cancer

09/01/25

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend that the targeted drug olaparib can be used for locally advanced or metastatic breast cancer.
See full story